{"id":"https://openalex.org/W4360844235","doi":"https://doi.org/10.1136/lupus-2022-000830","title":"Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data","display_name":"Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4360844235","doi":"https://doi.org/10.1136/lupus-2022-000830","pmid":"https://pubmed.ncbi.nlm.nih.gov/36963777","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10040006"},"language":"en","primary_location":{"id":"doi:10.1136/lupus-2022-000830","doi":"https://doi.org/10.1136/lupus-2022-000830","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2022-000830","pdf_url":"https://lupus.bmj.com/content/lupusscimed/10/1/e000830.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Science & Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://lupus.bmj.com/content/lupusscimed/10/1/e000830.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025335653","display_name":"David P. D\u2019Cruz","orcid":"https://orcid.org/0000-0002-6983-8421","observed_orcids":["https://orcid.org/0000-0002-6983-8421"]},"institutions":[{"id":"https://openalex.org/I1298207432","display_name":"Guy's Hospital","ror":"https://ror.org/04r33pf22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1298207432","https://openalex.org/I200166805","https://openalex.org/I4210111135"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David D'Cruz","raw_affiliation_strings":["Louise Coote Lupus Unit, Guy's Hospital, London, UK"],"raw_orcid":"https://orcid.org/0000-0002-6983-8421","affiliations":[{"raw_affiliation_string":"Louise Coote Lupus Unit, Guy's Hospital, London, UK","institution_ids":["https://openalex.org/I1298207432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014891183","display_name":"Gina Eriksson","orcid":"https://orcid.org/0000-0002-1179-2344","observed_orcids":["https://orcid.org/0000-0002-1179-2344"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gina Eriksson","raw_affiliation_strings":["Research and Development, GSK, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, GSK, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083359321","display_name":"Yulia Green","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yulia Green","raw_affiliation_strings":["Immunology, GSK, Brentford, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology, GSK, Brentford, Middlesex, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072719649","display_name":"Anne E. Hammer","orcid":"https://orcid.org/0000-0003-0217-3848","observed_orcids":["https://orcid.org/0000-0003-0217-3848"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Hammer","raw_affiliation_strings":["Immunology Biostatistics, GSK, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology Biostatistics, GSK, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036222488","display_name":"Beulah Ji","orcid":"https://orcid.org/0000-0002-9944-348X","observed_orcids":["https://orcid.org/0000-0002-9944-348X"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Beulah Ji","raw_affiliation_strings":["Research and Development, GSK, Brentford, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, GSK, Brentford, Middlesex, UK","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003433725","display_name":"Paige Meizlik","orcid":"https://orcid.org/0000-0002-2237-8552","observed_orcids":["https://orcid.org/0000-0002-2237-8552"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paige Meizlik","raw_affiliation_strings":["Global Safety, GSK, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Safety, GSK, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034488510","display_name":"David A. Roth","orcid":"https://orcid.org/0000-0001-8356-0457","observed_orcids":["https://orcid.org/0000-0001-8356-0457"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Roth","raw_affiliation_strings":["Research and Development, GSK, Collegeville, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, GSK, Collegeville, Pennsylvania, USA","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5025335653"],"corresponding_institution_ids":["https://openalex.org/I1298207432"],"apc_list":{"value":1950,"currency":"GBP","value_usd":2391},"apc_paid":{"value":1950,"currency":"GBP","value_usd":2391},"fwci":1.8818,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.84954881,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"1","first_page":"e000830","last_page":"e000830"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/belimumab","display_name":"belimumab","score":1.0},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.871999979019165},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.9769999980926514},{"id":"https://openalex.org/keywords/organ-damage","display_name":"organ damage","score":0.5950000286102295},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.7599999904632568},{"id":"https://openalex.org/keywords/sle-responder-index","display_name":"SLE Responder Index","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2781205201","wikidata":"https://www.wikidata.org/wiki/Q1996249","display_name":"Belimumab","level":5,"score":0.9826560020446777},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9021329879760742},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.786113977432251},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6731266379356384},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.655053973197937},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5772861838340759},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4932090640068054},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.48572975397109985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4778420627117157},{"id":"https://openalex.org/C170286685","wikidata":"https://www.wikidata.org/wiki/Q409346","display_name":"B-cell activating factor","level":4,"score":0.11789625883102417},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.11533454060554504},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08848735690116882},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07453680038452148},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05604499578475952},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.0},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/lupus-2022-000830","doi":"https://doi.org/10.1136/lupus-2022-000830","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2022-000830","pdf_url":"https://lupus.bmj.com/content/lupusscimed/10/1/e000830.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Science & Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10040006","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10040006","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10040006/pdf/lupus-2022-000830.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Sci Med","raw_type":"Text"},{"id":"pmid:36963777","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36963777","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus science & medicine","raw_type":"Randomized Controlled Trial"},{"id":"pmh:oai:doaj.org/article:238a809959434cd0bbf78b08d243c9e0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/238a809959434cd0bbf78b08d243c9e0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lupus Science and Medicine, Vol 10, Iss 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/lupus-2022-000830","doi":"https://doi.org/10.1136/lupus-2022-000830","is_oa":true,"landing_page_url":"https://doi.org/10.1136/lupus-2022-000830","pdf_url":"https://lupus.bmj.com/content/lupusscimed/10/1/e000830.full.pdf","source":{"id":"https://openalex.org/S2764956401","display_name":"Lupus Science & Medicine","issn_l":"2053-8790","issn":["2053-8790"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lupus Science & Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4360844235.pdf","grobid_xml":"https://content.openalex.org/works/W4360844235.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1583381149","https://openalex.org/W1982788020","https://openalex.org/W1987054275","https://openalex.org/W2003808955","https://openalex.org/W2069343534","https://openalex.org/W2096286605","https://openalex.org/W2131457901","https://openalex.org/W2136149088","https://openalex.org/W2139198208","https://openalex.org/W2775607224","https://openalex.org/W2782542157","https://openalex.org/W3101920302","https://openalex.org/W3111992615","https://openalex.org/W3164107804","https://openalex.org/W3174664171"],"related_works":["https://openalex.org/W3164107804","https://openalex.org/W4379795615","https://openalex.org/W4399998704","https://openalex.org/W3165652581","https://openalex.org/W4303453591","https://openalex.org/W7133205267","https://openalex.org/W2947702376","https://openalex.org/W7000111936","https://openalex.org/W2303962721","https://openalex.org/W4200111205"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Assess":[1],"the":[2,55,64,88,97,113,117,149,193,209,226],"safety":[3,23,46,90,119,214],"and":[4,93,125,142,155,169,181,192,215],"efficacy":[5,216],"of":[6,54,67,184,217,244],"belimumab":[7,29,204,218,230],"in":[8,87,96,179,219],"older":[9,82,102,129,159,190,220,236,245],"adults":[10,58,83,103,130,160,191,221],"with":[11,63,69,208,225,238,251],"SLE.":[12,70,239],"METHODS:":[13],"This":[14],"post":[15],"hoc":[16],"integrated":[17],"analysis":[18,91,120],"(GSK":[19],"Study":[20],"116559)":[21],"included":[22,86],"data":[24,47,50],"from":[25,52],"six":[26,156],"randomised,":[27],"placebo-controlled":[28],"trials":[30],"(BLISS-76,":[31],"BLISS-52,":[32],"BLISS-SC,":[33],"North":[34],"East":[35],"Asia":[36],"study,":[37,151],"LBSL02,":[38],"EMBRACE;":[39],"n=4170).":[40],"The":[41,213],"BASE":[42,98,150],"study":[43],"provided":[44],"additional":[45],"(n=4003).":[48],"Efficacy":[49],"were":[51,61,78,85,187,222],"five":[53,122],"trials.":[56],"Older":[57,196],"(\u226565":[59],"years)":[60],"compared":[62],"overall":[65,114,194,210,227],"populations":[66],"patients":[68,146,173,237],"Patients":[71],"who":[72],"had":[73,104],"received":[74],"\u22651":[75,132,162],"treatment":[76,233],"dose":[77],"included.":[79],"RESULTS:":[80],"Sixty-three":[81],"(1.5%)":[84],"pooled":[89,118],"population":[92],"156":[94],"(3.9%)":[95],"study.":[99],"At":[100],"baseline,":[101],"lower":[105],"disease":[106],"activity":[107],"but":[108],"more":[109],"organ":[110],"damage":[111],"than":[112],"populations.":[115,195],"In":[116,148],"population,":[121],"(18.5%)":[123],"placebo-treated":[124,141,154,168],"ten":[126],"(27.8%)":[127],"belimumab-treated":[128,145,158,172],"experienced":[131,161],"serious":[133],"adverse":[134,182],"event":[135],"(SAE),":[136],"as":[137,164],"did":[138,165],"230":[139],"(17.0%)":[140],"421":[143],"(15.0%)":[144],"overall.":[147,174],"nine":[152],"(11.0%)":[153,171],"(8.1%)":[157],"SAE,":[163],"222":[166],"(11.1%)":[167],"220":[170],"No":[175],"clinically":[176],"relevant":[177],"differences":[178],"deaths":[180],"events":[183],"special":[185],"interest":[186],"observed":[188],"between":[189],"adults'":[197],"SLE":[198],"Responder":[199],"Index":[200],"response":[201],"rates":[202],"favoured":[203],"versus":[205],"placebo,":[206],"consistent":[207,224],"population.":[211],"CONCLUSION:":[212],"generally":[223],"populations,":[228],"suggesting":[229],"is":[231],"a":[232],"option":[234],"for":[235],"Due":[240],"to":[241],"small":[242],"numbers":[243],"adults,":[246],"findings":[247],"should":[248],"be":[249],"interpreted":[250],"caution.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-03-25T00:00:00"}